STOCKHOLDERS' EQUITY AND NONCONTROLLING INTERESTS - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended
	Aug. 08, 2016 USD ($) shares	Jul. 01, 2016 USD ($)	Jul. 03, 2015 USD ($)	Jul. 01, 2016 € / shares	Jul. 01, 2016 USD ($)	Jul. 03, 2015 USD ($)	Jul. 01, 2016 USD ($) shares	Nov. 30, 2015 shares	Oct. 02, 2015 shares	[1]	Apr. 30, 2015
Stockholders’ equity and noncontrolling interests [Line Items]
Number of shares authorized to be repurchased by VMS Board of Directors (in shares)								8,000,000
Number of shares remain available for repurchase (in shares)							4,800,000
Total cost | $		$ 125,513	$ 92,389		$ 374,217	$ 293,570
Common stock, shares outstanding (in shares)							94,306,000		98,070,000
Noncontrolling Interests
Stockholders’ equity and noncontrolling interests [Line Items]
Redemption value | $							$ 10,300
MeVis Medical Solutions AG (MeVis)
Stockholders’ equity and noncontrolling interests [Line Items]
Percentage of voting interest acquired											73.50%
Annual recurring compensation (in euro per share) | € / shares				€ 0.95
Put right (in euro per share) | € / shares				€ 19.77
MeVis Medical Solutions AG (MeVis) | Noncontrolling Interests
Stockholders’ equity and noncontrolling interests [Line Items]
Common stock, shares outstanding (in shares)							480,000
Noncontrolling interest (as a percent)							26.40%
Accelerated Share Repurchase Program
Stockholders’ equity and noncontrolling interests [Line Items]
Total cost | $		$ 0	$ 70,000		$ 40,400	$ 115,000
Subsequent Event | Accelerated Share Repurchase Program With JP Morgan
Stockholders’ equity and noncontrolling interests [Line Items]
Total cost | $	$ 45,400
Repurchased (shares)	500,000

[1] The condensed consolidated balance sheet as of October 2, 2015 was derived from audited financial statements as of that date, but does not include all disclosures required by accounting principles generally accepted in the United States of America.